Efloxate

Efloxate
Clinical data
ATC code	C01DX13 (WHO) ;
Identifiers
	IUPAC name ethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate;
CAS Number	119-41-5 ;
PubChem CID	8395;
ChemSpider	8089;
UNII	CZU6V3902K;
ChEMBL	ChEMBL1349073;
Chemical and physical data
Formula	C19H16O5
Molar mass	324.332 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3;
	InChI InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3; Key:ZVXBAHLOGZCFTP-UHFFFAOYSA-N;
	(verify)

Efloxate is a vasodilator.^[1]

References

^ Tomasi AM, Masoni A (August 1977). "[Clinical research on the therapeutic efficacy and tolerance of long-acting efloxate in angina pectoris]". La Clinica Terapeutica (in Italian). 82 (3): 227–41. PMID 334448.{{cite journal}}: CS1 maint: unrecognized language (link)

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Clinical data

ATC code	C01DX13 (WHO)
Identifiers
IUPAC name ethyl 2-[(4-oxo-2-phenyl-4H-chromen-7-yl)oxy]acetate
CAS Number	119-41-5^Y
PubChem CID	8395
ChemSpider	8089
UNII	CZU6V3902K
ChEMBL	ChEMBL1349073
Chemical and physical data
Formula	C₁₉H₁₆O₅
Molar mass	324.332 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3
InChI InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3 Key:ZVXBAHLOGZCFTP-UHFFFAOYSA-N
(verify)